Over the last 7 days, the United States market has risen by 5.1%, and over the past year, it has climbed 11%, with earnings forecasted to grow by 14% annually. While penny stocks might evoke images of speculative trades from earlier market days, they still represent smaller or less-established companies that can offer significant value when chosen wisely. By focusing on those with robust financials and clear growth trajectories, investors can uncover promising opportunities in these often-overlooked segments of the market.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Rewards & Risks |
| Safe Bulkers (NYSE:SB) | $3.67 | $378.49M | ✅ 3 ⚠️ 3 View Analysis > |
| IDenta (OTCPK:IDTA) | $0.69888 | $3.03M | ✅ 2 ⚠️ 3 View Analysis > |
| Tuya (NYSE:TUYA) | $2.82 | $1.63B | ✅ 3 ⚠️ 3 View Analysis > |
| Flexible Solutions International (NYSEAM:FSI) | $4.33 | $56.16M | ✅ 4 ⚠️ 2 View Analysis > |
| Imperial Petroleum (NasdaqCM:IMPP) | $2.57 | $91.54M | ✅ 3 ⚠️ 2 View Analysis > |
| Table Trac (OTCPK:TBTC) | $4.49 | $21.34M | ✅ 2 ⚠️ 2 View Analysis > |
| BAB (OTCPK:BABB) | $0.805025 | $6.1M | ✅ 2 ⚠️ 3 View Analysis > |
| Dingdong (Cayman) (NYSE:DDL) | $2.47 | $507.9M | ✅ 4 ⚠️ 0 View Analysis > |
| Lifetime Brands (NasdaqGS:LCUT) | $3.38 | $74.3M | ✅ 3 ⚠️ 2 View Analysis > |
| CBAK Energy Technology (NasdaqCM:CBAT) | $0.8915 | $84.09M | ✅ 4 ⚠️ 1 View Analysis > |
Click here to see the full list of 763 stocks from our US Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Planet Image International (NasdaqCM:YIBO)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Planet Image International Limited manufactures and sells compatible toner cartridges under both white-label and self-owned brands across North America, Europe, and internationally, with a market cap of $92.68 million.
Operations: The company's revenue is primarily derived from its Printers & Related Products segment, totaling $149.83 million.
Market Cap: $92.68M
Planet Image International Limited, with a market cap of US$92.68 million, reported a slight decline in sales and net income for 2024 compared to the previous year, reflecting challenges in maintaining growth. The company's earnings are well-supported by its interest coverage ratio of 39.4x, and it holds more cash than total debt, indicating financial stability despite negative operating cash flow. While short-term assets cover both short- and long-term liabilities comfortably, the share price remains highly volatile. The Price-To-Earnings ratio suggests it is valued slightly below the US market average at 17.4x versus 17.9x.
- Click here to discover the nuances of Planet Image International with our detailed analytical financial health report.
- Understand Planet Image International's track record by examining our performance history report.
Performant Healthcare (NasdaqGS:PHLT)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Performant Healthcare, Inc. offers audit, recovery, and analytics services in the United States with a market cap of $202.04 million.
Operations: The company's revenue segment is Business Services, generating $128.92 million.
Market Cap: $202.04M
Performant Healthcare, Inc., with a market cap of US$202.04 million, continues to reduce its losses, reporting a net loss of US$0.081 million for Q1 2025 compared to a larger loss last year. Despite being unprofitable, the company has maintained positive free cash flow and sufficient cash runway for over three years. Revenue grew from US$27.33 million to US$33.27 million year-on-year for Q1 2025, supported by recent contracts like the New York State Medicaid Recovery Audit Contract commencing in Q2 2025. Analysts expect significant stock price appreciation and forecast revenue growth at 8.45% annually.
- Unlock comprehensive insights into our analysis of Performant Healthcare stock in this financial health report.
- Assess Performant Healthcare's future earnings estimates with our detailed growth reports.
Planet Labs PBC (NYSE:PL)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Planet Labs PBC designs, constructs, and launches satellite constellations to provide high cadence geospatial data via an online platform globally, with a market cap of approximately $1.14 billion.
Operations: The company generates revenue primarily from its data processing segment, which accounted for $244.35 million.
Market Cap: $1.14B
Planet Labs PBC, with a market cap of US$1.14 billion, leverages its extensive satellite network to secure significant multi-year contracts, such as those with EMDYN and the California Air Resource Board. Despite being unprofitable and having a negative return on equity of -27.92%, the company shows potential for revenue growth, forecasted at 15.86% annually. It remains debt-free with robust short-term assets exceeding liabilities by US$160 million and maintains a sufficient cash runway for over three years. The stock's high volatility reflects broader market trends in penny stocks, but strategic partnerships enhance its value proposition in global markets.
- Click to explore a detailed breakdown of our findings in Planet Labs PBC's financial health report.
- Learn about Planet Labs PBC's future growth trajectory here.
Key Takeaways
- Click through to start exploring the rest of the 760 US Penny Stocks now.
- Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Performant Healthcare might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com